Aug 11, 2020
List Labs Fields Upgraded Management Team
Apr 24, 2020
$8.8+ Billion Biodefense Industry Insight, 2027: Impact of COVID-19 on the Global Market
Apr 06, 2020
PureLine Treatment Systems, LLC Releases Validation Report Regarding Decontamination of N95 Respirator Masks via the Portable Dopke Decon System and Chlorine Dioxide Gas
Jan 14, 2020
MBio Diagnostics Announces New Contracts with SRI
Oct 23, 2019
BlueWillow Receives FDA Clearance to Begin Phase 1 Study of its Intranasal Anthrax Vaccine
Sep 17, 2019
University of Maryland, Baltimore Grants Spherix Exclusive Option to License Anthrax Based Ovarian Cancer Drug PrAg-PAS
May 29, 2019
BlueWillow Biologics Announces Issuance of Intranasal Anthrax Vaccine Patent
Feb 11, 2019
Soligenix Receives US Patent Expanding Protection for its Ricin Toxin Vaccine, RiVax®
Dec 14, 2018
The Global Market for Anthrax Treatment (2019-2023) - Bayer, Elusys Therapeutics and Emergent BioSolutions are the Leading Players
Oct 04, 2018
Russia accuses US of running bio arms lab in Georgia
Apr 23, 2018
Elusys Receives Second Delivery Order From U.S. Government for ANTHIM®, its Treatment for Inhalation Anthrax
Oct 10, 2017
Elusys Delivers First Shipment Of ANTHIM®, Its Treatment For Inhalation Anthrax, To The U.S. Government Strategic National Stockpile
Jun 19, 2017
NanoBio And Porton Biopharma Receive Approval To Advance Next Generation Anthrax Vaccine
Jun 15, 2017
Protein Potential, LLC Publishes on its Anthrax and Shigellosis Vaccines Based on Oral Typhoid Fever Vaccine Platform